Cagrilintide vs Retatrutide | Research Comparison | QSC

Cagrilintide vs Retatrutide

Mechanism, Phase 2 data, and research applications compared

Shop Both at QSC →

Factor Cagrilintide Retatrutide
Receptor AMY1R (amylin-1) GLP-1R+GIPR+GCGR
Best Trial Result −15.6% CagriSema (32wks) −24.2% (48wks)
At QSC ✓ In Stock ✓ In Stock
Research analysis: Retatrutide leads in monotherapy; cagrilintide in combination with GLP-1 agonists offers complementary mechanism.
Research Use Only. All QSC products for in vitro laboratory research only.
Peptides
Orals
Oils
Search
Contact